Your search for "alzheimer" found 38 search results. Showing results 11 - 20 of 38.
Good Ventures awarded a gift of $4,000,000 over five years to Mass Eye and Ear to support research by Harvard faculty member Joseph F. Arboleda-Velásquez, M.D., Ph.D., on the identity and function of genes that delay the onset of Alzheimer’s disease in humans. The research will aim to identify protective… Read More
Good Ventures awarded a grant of $265,000 to the Kaiser Permanente Center for Health Research to support research by Dr. Sheila Weinmann and colleagues on the impact of herpes infections and antiviral drugs on the incidence of Alzheimer’s disease. This research will analyze existing data to evaluate whether administering an… Read More
Good Ventures awarded a grant of $5,300,000 over four years to Washington University to support research on Alzheimer’s disease by Professor Brendan Lucey, Professor David Holtzman, and colleagues. Professors Lucey and Holtzman will conduct a clinical trial on the impact of treatment with the sleep-inducing drug suvorexant on the progression of early-stage Alzheimer’s… Read More
Good Ventures awarded a grant of $229,225 to the Veterans Education and Research Association of Northern New England for research to investigate the association between herpes virus infections and risk of developing dementia, as well as the effects of anti-herpetic medications on this risk. The work is led by Yinong Young-Xu, ScD, MA,… Read More
Good Ventures awarded a grant of $33,941 to Cure Alzheimer's Fund to support the annual meeting of their Research Leadership Group held in February 2019. Good Ventures, with support from the Open Philanthropy Project, has been investigating how best to fund scientific research that might help reduce the future… Read More
Good Ventures awarded a grant of $275,000 over two years to Cincinnati Children’s Hospital Medical Center to complete an analysis of the impact of Herpes Simplex Virus 1 on Alzheimer’s pathology in mice. Preliminary results suggest that during reactivation, HSV1 can spread through facial nerves to the brain. In the… Read More
Good Ventures awarded a gift of $176,000 to Stanford University to support research led by Professor Carla Shatz into factors associated with cognitive impairment in Alzheimer’s disease (AD). It is increasingly thought to be the case that the cognitive impairment that accompanies AD is associated with synaptic pruning in which… Read More
Good Ventures awarded a grant of $760,000 to Massachusetts General Hospital (MGH) to support the continuation of a study led by Professors Rudolph Tanzi and Robert Moir on the impact of foreign organisms in the brain in Alzheimer's disease (AD). We previously awarded these investigators funds to explore the idea that… Read More
Good Ventures awarded a grant of $4,247,744 over three years to Brigham and Women’s Hospital to support development of a blood-based diagnostic test for Alzheimer’s disease. Good Ventures, with support from the Open Philanthropy Project, has been investigating how best to fund scientific research that might help reduce the future burden of Alzheimer’s disease. A… Read More
Good Ventures awarded a grant of $2,546,962 over three years to Massachusetts General Hospital to support research on Alzheimer's disease conducted by Professor Rudolph Tanzi and colleagues. Good Ventures, with support from the Open Philanthropy Project, has been investigating how best to fund scientific research that might help reduce… Read More